Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Research|July 1, 1986
Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in miceS D Harrison, P J O'Dwyer, M W Trader
Cancer Treatment Reports|July 1, 1981
Synergistic antileukemic activity of combinations of two nitrosoureasG P Wheeler, F M Schabel, M W Trader
Cancer Treatment Reports|May 1, 1978
Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemiaW C Rose, M W Trader, W R Laster, et al.
Antibiotics and Chemotherapy|January 1, 1978
Patterns of resistance and therapeutic synergism among alkylating agentsF M Schabel, M W Trader, W R Laster, et al.
Investigational New Drugs|December 1, 1987
Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivoS D Harrison, R W Brockman, M W Trader, et al.
Biochemical Pharmacology|October 1, 1982
Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexateJ D Strobel-Stevens, S M El Dareer, M W Trader, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II)L J Wilkoff, E A Dulmadge, M W Trader, et al.
Cancer Treatment Reports|December 1, 1978
Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumorsW C Rose, M W Trader, D J Dykes, et al.
British Journal of Cancer|January 1, 1983
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamideR F Struck, D J Dykes, T H Corbett, et al.
Cancer Treatment Reports|September 11, 1976
Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNUF M Schabel, M W Trader, W R Laster, et al.
Pageof 2